On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C-Reference-Cited by-同舟云学术

On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C

Published:2017-06-15 Issue:6 Volume:12 Page:e0179096
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chu Po-sung^ORCID,Nakamoto Nobuhiro,Taniki Nobuhito,Ojiro Keisuke,Amiya Takeru,Makita Yuko,Murata Hiroko,Yamaguchi Akihiro,Shiba Shunsuke,Miyake Rei,Katayama Tadashi,Ugamura Aya,Ikura Akihiko,Takeda Karin,Ebinuma Hirotoshi,Saito Hidetsugu,Kanai Takanori

Funder

Japan Agency for Medical Research and Development

Keio Gijuku Academic Development Funds

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Immunity, inflammation, and cancer;SI Grivennikov;Cell,2010

2. EASL Recommendations on Treatment of Hepatitis C 2015;Journal of hepatology,2015

3. APASL consensus statements and recommendation on treatment of hepatitis C;M Omata;Hepatology international,2016

4. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus;AG Singal;Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association,2010

5. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies;RL Morgan;Annals of internal medicine,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

2. Natural killer group 2D‐major histocompatibility complex class I polypeptide‐related sequence A activation enhances natural killer cell‐mediated immunity against hepatocellular carcinoma: A review;Hepatology Research;2024-03-27

3. Hepatitis C Virus-Related One-Year Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial;Journal of Gastrointestinal Cancer;2024-03-04

4. Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment;Hepatology Communications;2024-02-14

5. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment;Journal of the Formosan Medical Association;2024-01